Are you sure you want to leave?
Access leaflets and other resources about chronic kidney disease–mineral and bone disorder (CKD–MBD) and the challenges of treating secondary hyperparathyroidism (SHPT).
You are viewing a website from Vifor Pharma. This material is only intended for healthcare professionals (“HCPs”) from Europe. If you are not the intended audience, please leave this website. By checking the box, you acknowledge that you are a HCP from Europe. Approval conditions for products may vary from country to country. Before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.